Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway: a retrospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway : a retrospective cohort study. / Jørgensen, Sara Falk; Ravn, Pernille; Thorsen, Søren; Worm, Signe Westring.

In: BMC Cancer, Vol. 17, 809, 02.12.2017.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jørgensen, SF, Ravn, P, Thorsen, S & Worm, SW 2017, 'Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway: a retrospective cohort study', BMC Cancer, vol. 17, 809. https://doi.org/10.1186/s12885-017-3826-z

APA

Jørgensen, S. F., Ravn, P., Thorsen, S., & Worm, S. W. (2017). Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway: a retrospective cohort study. BMC Cancer, 17, [809]. https://doi.org/10.1186/s12885-017-3826-z

Vancouver

Jørgensen SF, Ravn P, Thorsen S, Worm SW. Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway: a retrospective cohort study. BMC Cancer. 2017 Dec 2;17. 809. https://doi.org/10.1186/s12885-017-3826-z

Author

Jørgensen, Sara Falk ; Ravn, Pernille ; Thorsen, Søren ; Worm, Signe Westring. / Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway : a retrospective cohort study. In: BMC Cancer. 2017 ; Vol. 17.

Bibtex

@article{52327370d4894a40ad5ede5a833e9873,
title = "Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway: a retrospective cohort study",
abstract = "Background: In 2012 a new cancer patient pathway for patients with non-specific symptoms and signs of cancer (NSSC-CPP) was introduced in Denmark. Limited information is available about the patients referred to the NSSC-CPP and the investigational course. The aim was to describe the population and the investigational course, estimate the prevalence of cancer and one-year mortality, and identify factors associated with a subsequent cancer diagnosis in patients referred to the NSSC-CPP. Method: This cohort study included patients with at least one visit at the NSSC-CPP at North Zealand Hospital in Denmark (NOH) from October 1st 2013 to September 30th 2014. Data was based on retrospective reviews of the patient files. Logistic regression identified factors associated with a subsequent cancer diagnosis. Multivariate analyses were adjusted by age, gender, smoking status and alcohol consumption. Kaplan-Meier survival plots were made at one-year follow-up. Results: Eight hundred twenty-five patients were included with a median age of 67 years, 47.4% were male. Prevalence of cancer within one year was 16.7% (138/825). 70.3% (97/138) were solid cancers and 29.7% (41/138) were haematological cancers. During the investigational course 76.7% went through advanced diagnostic imaging (ultrasound, CT, FDG-PET/CT or MRI). Anaemia (OR1.63 CI1.02-2.60), leucocytosis (OR 2.06 CI 1.34-3.15), thrombocytopenia (OR 4.13 CI 2.02-8.47) and elevated LDH (OR 1.64 CI 1.07-2.52) and CRP (OR 2.56 CI 1.66-3.95) were associated with a cancer diagnosis when adjusting for possible confounders. No single non-specific symptom was significantly associated with a cancer diagnosis. One-year mortality for those diagnosed with cancer was 44.2%. Conclusion: The prevalence of cancer matches that of another NSSC-CPP in Denmark. Deviations in basic biochemistry were associated with a higher probability of underlying cancer and could possibly raise the level of suspicion of malignancy among physicians. High one-year mortality was seen amongst patients diagnosed with cancer.",
keywords = "Cancer, Denmark, Fast-track, Non-specific symptoms, One-year mortality",
author = "J{\o}rgensen, {Sara Falk} and Pernille Ravn and S{\o}ren Thorsen and Worm, {Signe Westring}",
year = "2017",
month = dec,
day = "2",
doi = "10.1186/s12885-017-3826-z",
language = "English",
volume = "17",
journal = "B M C Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway

T2 - a retrospective cohort study

AU - Jørgensen, Sara Falk

AU - Ravn, Pernille

AU - Thorsen, Søren

AU - Worm, Signe Westring

PY - 2017/12/2

Y1 - 2017/12/2

N2 - Background: In 2012 a new cancer patient pathway for patients with non-specific symptoms and signs of cancer (NSSC-CPP) was introduced in Denmark. Limited information is available about the patients referred to the NSSC-CPP and the investigational course. The aim was to describe the population and the investigational course, estimate the prevalence of cancer and one-year mortality, and identify factors associated with a subsequent cancer diagnosis in patients referred to the NSSC-CPP. Method: This cohort study included patients with at least one visit at the NSSC-CPP at North Zealand Hospital in Denmark (NOH) from October 1st 2013 to September 30th 2014. Data was based on retrospective reviews of the patient files. Logistic regression identified factors associated with a subsequent cancer diagnosis. Multivariate analyses were adjusted by age, gender, smoking status and alcohol consumption. Kaplan-Meier survival plots were made at one-year follow-up. Results: Eight hundred twenty-five patients were included with a median age of 67 years, 47.4% were male. Prevalence of cancer within one year was 16.7% (138/825). 70.3% (97/138) were solid cancers and 29.7% (41/138) were haematological cancers. During the investigational course 76.7% went through advanced diagnostic imaging (ultrasound, CT, FDG-PET/CT or MRI). Anaemia (OR1.63 CI1.02-2.60), leucocytosis (OR 2.06 CI 1.34-3.15), thrombocytopenia (OR 4.13 CI 2.02-8.47) and elevated LDH (OR 1.64 CI 1.07-2.52) and CRP (OR 2.56 CI 1.66-3.95) were associated with a cancer diagnosis when adjusting for possible confounders. No single non-specific symptom was significantly associated with a cancer diagnosis. One-year mortality for those diagnosed with cancer was 44.2%. Conclusion: The prevalence of cancer matches that of another NSSC-CPP in Denmark. Deviations in basic biochemistry were associated with a higher probability of underlying cancer and could possibly raise the level of suspicion of malignancy among physicians. High one-year mortality was seen amongst patients diagnosed with cancer.

AB - Background: In 2012 a new cancer patient pathway for patients with non-specific symptoms and signs of cancer (NSSC-CPP) was introduced in Denmark. Limited information is available about the patients referred to the NSSC-CPP and the investigational course. The aim was to describe the population and the investigational course, estimate the prevalence of cancer and one-year mortality, and identify factors associated with a subsequent cancer diagnosis in patients referred to the NSSC-CPP. Method: This cohort study included patients with at least one visit at the NSSC-CPP at North Zealand Hospital in Denmark (NOH) from October 1st 2013 to September 30th 2014. Data was based on retrospective reviews of the patient files. Logistic regression identified factors associated with a subsequent cancer diagnosis. Multivariate analyses were adjusted by age, gender, smoking status and alcohol consumption. Kaplan-Meier survival plots were made at one-year follow-up. Results: Eight hundred twenty-five patients were included with a median age of 67 years, 47.4% were male. Prevalence of cancer within one year was 16.7% (138/825). 70.3% (97/138) were solid cancers and 29.7% (41/138) were haematological cancers. During the investigational course 76.7% went through advanced diagnostic imaging (ultrasound, CT, FDG-PET/CT or MRI). Anaemia (OR1.63 CI1.02-2.60), leucocytosis (OR 2.06 CI 1.34-3.15), thrombocytopenia (OR 4.13 CI 2.02-8.47) and elevated LDH (OR 1.64 CI 1.07-2.52) and CRP (OR 2.56 CI 1.66-3.95) were associated with a cancer diagnosis when adjusting for possible confounders. No single non-specific symptom was significantly associated with a cancer diagnosis. One-year mortality for those diagnosed with cancer was 44.2%. Conclusion: The prevalence of cancer matches that of another NSSC-CPP in Denmark. Deviations in basic biochemistry were associated with a higher probability of underlying cancer and could possibly raise the level of suspicion of malignancy among physicians. High one-year mortality was seen amongst patients diagnosed with cancer.

KW - Cancer

KW - Denmark

KW - Fast-track

KW - Non-specific symptoms

KW - One-year mortality

U2 - 10.1186/s12885-017-3826-z

DO - 10.1186/s12885-017-3826-z

M3 - Journal article

C2 - 29197366

AN - SCOPUS:85036597049

VL - 17

JO - B M C Cancer

JF - B M C Cancer

SN - 1471-2407

M1 - 809

ER -

ID: 189700456